［1］Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating irondependent, nonapoptotic cell death in oncogenicrasharboring cancer cells\[J\].Chem Biol,2008,15(3):234-245.

［2］Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an irondependent form of nonapoptotic cell death\[J\].Cell,2012,149(5):1060-1072.

［3］Yagoda N, Von Rechenberg M, Zaganjor E, et al. RASRAFMEKdependent oxidative cell death involving voltagedependent anion channels\[J\].Nature,2007,447(7146):864-868.

［4］Angeli JPF, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator gpx4 triggers acute renal failure in mice\[J\].Nat Cell Biol,2014,16(12):1180-1191.

［5］Yang WS, Sriramaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by gpx4 \[J\].Cell,2014,156(1-2):317-331.

［6］Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation\[J\].Trends Cell Biol,2016,26(3):165-176.

［7］Gao M, Monian P, Quadri N, et al. Glutaminolysis and transferrin regulate ferroptosis\[J\].Mol Cell,2015,59(2):298-308.

［8］Xu T, Ding W, Ji X, et al. Molecular mechanisms of ferroptosis and its role in cancer therapy\[J\].J Cell Mol Med,2019,23(8):4900-4912.

［9］Wu Y, Song J, Wang Y, et al. The potential role of ferroptosis in neonatal brain injury\[J\].Front Neurosci,2019,13:115.

［10］Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: aregulated cell death nexus linking metabolism, redox biology, and disease\[J\].Cell,2017,171(2):273-285.

［11］Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer\[J\].J Hematol Oncol,2019,12(1):34.

［12］Skouta R, Dixon SJ, Wang J, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models\[J\].J Am Chem Soc,2014,136(12):4551-4556.

［13］Alvarez SW, Sviderskiy VO, Terzi EM, et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis\[J\].Nature,2017,551(7682):639-643.

［14］Louandre C, Marcq I, Bouhlal H, et al. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells\[J\].Cancer Lett,2015,356(2 Pt B):971-977.

［15］Hassannia B, Wiernicki B, Ingold I, et al. Nanotargeted induction of dual ferroptotic mechanisms eradicates highrisk neuroblastoma\[J\].J Clin Invest,2018,128(8):3341-3355.

［16］Ursini F, Maiorino M, Brigeliusflohe R, et al. Diversity of glutathioneperoxidases\[M\].Sandiego:Elsevieracademic pressinc,1995:38-53.

［17］Shimada K, Skouta R, Kaplan A, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis\[J\].Nat Chem Biol,2016,12(7):497-503.

［18］Yu H, Guo P, Xie X, et al. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases\[J\].J Cell Mol Med,2017,21(4):648-657.

［19］Sato H, Tamba M, Ishii T, et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins\[J\].J Biol Chem,1999,274(17):11455-11458.

［20］Bridges RJ, Natale NR, Patel SA. System Xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS\[J\].Br J Pharmacol,2012,165(1):20-34.

［21］Lu SC. Regulation of glutathione synthesis\[J\].Mol Aspects Med,2009,30(1-2):42-59.

［22］Jiang L, Hickman JH, Wang SJ, et al. Dynamic roles of p53mediated metabolic activities in ROSinduced stress responses\[J\].Cell Cycle,2015,14(18):2881-2885.

［23］Jiang L, Kon N, Li T, et al. Ferroptosis as a p53mediated activity during tumour suppression\[J\].Nature,2015,520(7545):57-62.

［24］Xie Y, Zhu S, Song X, et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity\[J\].Cell Rep,2017,20(7):1692-1704.

［25］Liu DS, Duong CP, Haupt S, et al. Inhibiting the system xC-/glutathione axis selectively targets cancers with mutantp53 accumulation\[J\].Nat Commun,2017,8:14844.

［26］Baker MA, Lane DJR, Ly JD, et al. VDAC1 is a transplasma membrane NADHferricyanide reductase\[J\].J Biol Chem,2004,279(6):4811-4819.

［27］Xia X, Fan X, Zhao M, et al. The relationship between ferroptosis and tumors: anovel landscape for therapeutic approach\[J\].Curr Gene Ther,2019,19(2):117-124.

［28］Song Y, Yang H, Lin R, et al. The role of ferroptosis in digestive system cancer\[J\].Oncol Lett,2019,18(3):2159-2164.

［29］Chen G, Guo GQ, Zhou XD, et al. Potential mechanism of ferroptosis in pancreatic cancer (Review)\[J\].Oncol Lett,2020,19(1):579-587.

［30］Sun X, Ou Z, Xie M, et al. HSPB1 as a novel regulator of ferroptotic cancer cell death\[J\].Oncogene,2015,34(45):5617-5625.

［31］Yamaguchi H, Hsu JL, Chen CT, et al. Caspaseindependent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in nonsmall cell lung cancer cells\[J\].Clin Cancer Res,2013,19(4):845-854.

［32］Chen L, Li X, Liu L, et al. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathioninegammalyase function\[J\].Oncol Rep,2015,33(3):1465-1474.

［33］Roh JL, Kim EH, Jang HJ, et al. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer\[J\].Cancer Lett,2016,381(1):96-103.

［34］Lin R, Zhang Z, Chen L, et al. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells\[J\].Cancer Lett,2016,381(1):165-175.

［35］Greenshields AL, Shepherd TG, Hoskin DW. Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the antimalarial drug artesunate\[J\].Mol Carcinog,2017,56(1):75-93.

［36］Efferth T. Willmar Schwabe Award 2006: Antiplasmodial and antitumor activity of arternisininfrom bench to bedside\[J\].Planta Med,2007,73(4):299-309.

［37］Basuli D, Tesfay L, Deng Z, et al. Iron addiction: a novel therapeutic target in ovarian cancer\[J\].Oncogene,2017,36(29):4089-4099.

［38］Yuan H, Li X, Zhang X, et al. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation\[J\].Biochem Biophys Res Commun,2016,478(2):838-844.

［39］Louandre C, Ezzoukhry Z, Godin C, et al. Irondependent cell death of hepatocellular carcinoma cells exposed to sorafenib\[J\].Int J Cancer,2013,133(7):1732-1742.

［40］Bai T, Wang S, Zhao Y, et al. Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells\[J\].Biochem Bioph Res Co,2017,491(4):919-925.

［41］Ou W, Mulik RS, Anwar A, et al. Lowdensity lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma\[J\].Free Radic Biol Med,2017,112:597-607.

［42］Sun X, Niu X, Chen R, et al. Metallothionein1G facilitates sorafenib resistance through inhibition of ferroptosis\[J\].Hepatology,2016,64(2):488-500.

［43］Sun X, Ou Z, Chen R, et al. Activation of the p62Keap1NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells\[J\].Hepatology,2016,63(1):173-184.

［44］Eling N, Reuter L, Hazin J, et al. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells\[J\].Oncoscience,2015,2(5):517-532.

［45］Lo M, Ling V, Wang YZ, et al. The Xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance\[J\].Br J Cancer,2008,99(3):464-472.

［46］Schott C, Graab U, Cuvelier N, et al. Oncogenic rasmutants confer resistance of rms13 rhabdomyosarcoma cells to oxidative stressinduced ferroptotic celldeath\[J\].Front Oncol,2015,5:131.